Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 637065, 20 pages
http://dx.doi.org/10.1155/2014/637065
Review Article

Vascular Calcification and Renal Bone Disorders

1Division of Nephrology, Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City 23148, Taiwan
2Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan
3Division of Nephrology, Department of Internal Medicine, Yonghe Cardinal Tien Hospital, 80 Zhongxing Street, Yonghe District, New Taipei City 23445, Taiwan

Received 30 March 2014; Revised 15 June 2014; Accepted 28 June 2014; Published 17 July 2014

Academic Editor: Keiju Hiromura

Copyright © 2014 Kuo-Cheng Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [30 citations]

The following is the list of published articles that have cited the current article.

  • Aline G. Costa, John P. Bilezikian, and E. Michael Lewiecki, “The potential use of antisclerostin therapy in chronic kidney disease - Mineral and bone disorder,” Current Opinion in Nephrology and Hypertension, vol. 24, no. 4, pp. 324–329, 2015. View at Publisher · View at Google Scholar
  • Vin-Cent Wu, Kuo-How Huang, Kang-Yung Peng, Yao-Chou Tsai, Che-Hsiung Wu, Shuo-Meng Wang, Shao-Yu Yang, Lian-Yu Lin, Chin-Chen Chang, Yen-Hung Lin, Shuei-Liong Lin, Tzong-Shinn Chu, and Kwan-Dun Wu, “Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population,” Scientific Reports, vol. 5, pp. 11396, 2015. View at Publisher · View at Google Scholar
  • Susan C. Schiavi, “Sclerostin and CKD-MBD,” Current Osteoporosis Reports, vol. 13, no. 3, pp. 159–165, 2015. View at Publisher · View at Google Scholar
  • Sun Chul Kim, Hyo Jung Chang, Myung-Gyu Kim, Sang-Kyung Jo, Won-Yong Cho, and Hyoung-Kyu Kim, “Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients,” Kidney Research and Clinical Practice, vol. 34, no. 1, pp. 28–34, 2015. View at Publisher · View at Google Scholar
  • Jordi Bover, Pieter Evenepoel, Pablo Urena-Torres, Marc G. Vervloet, Vincent Brandenburg, Sandro Mazzaferro, Adrian Covic, David Goldsmith, Ziad A. Massy, and Mario Cozzolino, “Pro: Cardiovascular calcifications are clinically relevant,” Nephrology Dialysis Transplantation, vol. 30, no. 3, pp. 345–351, 2015. View at Publisher · View at Google Scholar
  • David H. Smith, Eric S. Johnson, Denise M. Boudreau, Andrea E. Cassidy-Bushrow, Stephen P. Fortmann, Robert T. Greenlee, Jerry H. Gurwitz, David J. Magid, Catherine J. McNeal, Kristi Reynolds, Steven R. Steinhubl, Micah Thorp, Jeffrey O. Tom, Suma Vupputuri, Jeffrey J. VanWormer, Jessica Weinstein, Xiuhai Yang, Alan S. Go, and Stephen Sidney, “Comparative Effectiveness of Statin Therapy in Chronic Kidney Disease and Acute Myocardial Infarction: A Retrospective Cohort Study,” American Journal Of Medicine, vol. 128, no. 11, 2015. View at Publisher · View at Google Scholar
  • Rosa M. A. Moyses, and Susan C. Schiavi, “Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder,” Seminars In Dialysis, vol. 28, no. 6, pp. 578–586, 2015. View at Publisher · View at Google Scholar
  • L. Yu. Milovanova, Yu. S. Milovanov, D. V. Kudryavtseva, M. M. Markina, S. Yu. Milovanova, L. V. Kozlovskaya, M. V. Lebedeva, V. D. Beketov, S. V. Moiseev, N. A. Mukhin, V. V. Fomin, and A. A. Svistunov, “Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease,” Terapevticheskii arkhiv, vol. 87, no. 6, pp. 10, 2015. View at Publisher · View at Google Scholar
  • Zhao-Feng Wu, Ling Wang, De-Hong Feng, Ji-Jun Zhao, and Li Cheng, “MicroRNA-145 mediates steroid-induced necrosis of the femoral head by targeting the OPG/RANK/RANKL signaling pathway,” PLoS ONE, vol. 11, no. 7, 2016. View at Publisher · View at Google Scholar
  • Cai-Mei Zheng, Jin-Quan Zheng, Chia-Chao Wu, Chien-Lin Lu, Jia-Fwu Shyu, Hsu Yung-Ho, Mei-Yi Wu, I-Jen Chiu, Yuan-Hung Wang, Yuh-Feng Lin, and Kuo-Cheng Lu, “Bone loss in chronic kidney disease: Quantity or quality?,” Bone, vol. 87, pp. 57–70, 2016. View at Publisher · View at Google Scholar
  • Yue-xian Shi, Wei Si, Jun-duo Liu, Min Gao, Si-yuan Wang, Mei Cheng, and Yue Zhao, “Development and Evaluation of the Psychometric Properties of the CKD-MBD Knowledge and Behavior (CKD-MBD-KB) Questionnaire for Patients With Chronic K,” Journal Of Pain And Symptom Management, vol. 51, no. 3, pp. 557–+, 2016. View at Publisher · View at Google Scholar
  • Kuo-Cheng Lu, and Wen-Chih Liu, “The pleiotropic effects of uremic oral sorbent AST-120 in chronic kidney disease,” Journal of Internal Medicine of Taiwan, vol. 27, no. 6, pp. 317–332, 2016. View at Publisher · View at Google Scholar
  • Jordi Bover, María Jesús Lloret, Pamela Chang, José Ballarín, José Luis Górriz, Pablo Ureña-Torres, César Ruiz-García, Iara daSilva, and Mariano Rodríguez, “Detection of cardiovascular calcifications: Is it a useful tool for nephrologists?,” Nefrologia, vol. 36, no. 6, pp. 587–596, 2016. View at Publisher · View at Google Scholar
  • Jordi Bover, Pablo Ureña-Torres, María Jesús Lloret, Iara da Silva, César Ruiz-García, Pamela Chang, José Ballarín, José Luis Górriz, and Mariano Rodríguez, “Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications,” Nefrologia, vol. 36, no. 6, pp. 597–608, 2016. View at Publisher · View at Google Scholar
  • Jordi Bover, José Luis Górriz, Pablo Ureña-Torres, María Jesús Lloret, César Ruiz-García, Iara daSilva, Pamela Chang, Mariano Rodríguez, and José Ballarín, “Detection of cardiovascular calcifications: Is it a useful tool for nephrologists?,” Nefrología (English Edition), vol. 36, no. 6, pp. 587–596, 2016. View at Publisher · View at Google Scholar
  • Jordi Bover, Pablo Ureña-Torres, José Luis Górriz, María Jesús Lloret, Iara da Silva, César Ruiz-García, Pamela Chang, Mariano Rodríguez, and José Ballarín, “Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications,” Nefrología (English Edition), vol. 36, no. 6, pp. 597–608, 2016. View at Publisher · View at Google Scholar
  • Kun Zhang, Jingwei Gao, Jie Chen, Qingqing Cai, Pinming Liu, Hui Huang, and Xun Liu, “MICS, an easily ignored contributor to arterial calcification in CKD patients,” American Journal of Physiology - Renal Physiology, vol. 311, no. 4, pp. F663–F670, 2016. View at Publisher · View at Google Scholar
  • Ilhan Kurultak, Ilhan Kiliç, Betül Sezer, Sedat Tuncel, Ebru Taştekin, and Sedat Üstündaǧ, “Endocarditis and calcific uremic arteriolopathy: Is it a coincidence or an association? Case report,” Turkish Nephrology, Dialysis and Transplantation Journal, vol. 25, pp. 113–117, 2016. View at Publisher · View at Google Scholar
  • Sriram Ravindran, Dhivya Mohan, Eswari Dhivya Balasubramanian, and Gino A. Kurian, “Renal mitochondria can withstand hypoxic/ischemic injury secondary to renal failure in uremic rats pretreated with sodium thiosulfate,” Indian Journal of Pharmacology, vol. 49, no. 4, pp. 317–321, 2017. View at Publisher · View at Google Scholar
  • Cristiana David, Jordi Bover, Cornelia Voiculet, Ileana Peride, Lucian Cristian Petcu, Ionel Alexandru Checherita, Andrei Niculae, and Adrian Covic, “Coronary risk score for mineral bone disease in chronic non-diabetic hemodialysis patients: results from a prospective pilot study,” International Urology and Nephrology, vol. 49, no. 4, pp. 689–700, 2017. View at Publisher · View at Google Scholar
  • Gregor Jereb, Borut Poljšak, and Ivan Eržen, “Contribution of Drinking Water Softeners to Daily Phosphate Intake in Slovenia,” International Journal of Environmental Research and Public Health, vol. 14, no. 10, pp. 1186, 2017. View at Publisher · View at Google Scholar
  • Sinan Çalişkan, Azad Hekimoǧlu, Osman Çelikay, Tolga Biçer, Başol Canbakan, Mehmet D. Ayli, and Canan Gürdal, “Association between Conjunctival and Corneal Calcification and Atherosclerotic Changes in the Carotid Artery in Maintenance Hemodialysis Patients,” Cornea, vol. 36, no. 1, pp. 68–73, 2017. View at Publisher · View at Google Scholar
  • Yi-Chou Hou, Wen-Chih Liu, Cai-Mei Zheng, Jing-Quan Zheng, Tzung-Hai Yen, and Kuo-Cheng Lu, “Role of Vitamin D in Uremic Vascular Calcification,” BioMed Research International, vol. 2017, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Wen-Chih Liu, Chia-Chao Wu, Paik-Seong Lim, Shiaw-Wen Chien, Yi-Chou Hou, Cai-Mei Zheng, Jia-Fwu Shyu, Yuh-Feng Lin, and Kuo-Cheng Lu, “Effect of uremic toxin-indoxyl sulfate on the skeletal system,” Clinica Chimica Acta, vol. 484, pp. 197–206, 2018. View at Publisher · View at Google Scholar
  • Wen-Chih Liu, Yasuhiko Tomino, and Kuo-Cheng Lu, “Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120,” Toxins, vol. 10, no. 9, pp. 367, 2018. View at Publisher · View at Google Scholar
  • Edith Viridiana Alatorre-Moreno, José Ignacio Cerrillos-Gutiérrez, Jorge Andrade-Sierra, Enrique Rojas-Campos, Sandra Carrillo-Ibarra, Sonia Sifuentes-Franco, Andrés García-Sánchez, and Alejandra Guillermina Miranda-Díaz, “Vascular Calcification and Oxidative DNA Damage as Nontraditional Cardiovascular Risk Factors in Chronic Renal Disease,” Free Radicals, Antioxidants and Diseases, 2018. View at Publisher · View at Google Scholar
  • Lies Moonen, Patrick D’Haese, and Benjamin Vervaet, “Epithelial Cell Cycle Behaviour in the Injured Kidney,” International Journal of Molecular Sciences, vol. 19, no. 7, pp. 2038, 2018. View at Publisher · View at Google Scholar
  • Asokan Devarajan, “Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases,” Clinical Science, vol. 132, no. 6, pp. 615–626, 2018. View at Publisher · View at Google Scholar
  • Violeta Cazaña-Pérez, Pilar Cidad, Javier Donate-Correa, Ernesto Martín-Núñez, José R. López-López, M. Teresa Pérez-García, Teresa Giraldez, Juan F. Navarro-González, and Diego Alvarez de la Rosa, “Phenotypic Modulation of Cultured Primary Human Aortic Vascular Smooth Muscle Cells by Uremic Serum,” Frontiers in Physiology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Symeon Tournis, and Konstatinos Makris, “Clinical Use of Bone Turnover Markers in Osteoporosis,” Reference Module in Biomedical Sciences, 2018. View at Publisher · View at Google Scholar